San Francisco, CA -- Novela Neurotech, a neurotechnology company developing next-generation neural prosthesis for epilepsy treatment, will showcase its prototype system at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, January 13-16, 2020.
Millions of Americans suffer from epilepsy and do not respond to drug treatment. Novela is developing a wireless implantable system that monitors brain activity for signs of oncoming seizure activity, disrupts those activity patterns through electrical stimulation, and thus stop seizures in their track. The device, smaller than the tip of a finger, is production ready and being tested at the University of Toronto's Division of Comparative Medicine in Ontario, Canada, and the San Carlos Clinical Hospital in Madrid, Spain.
"Many of today's neurological disorders including epilepsy and depression are difficult to manage with medical drugs without side effects. Our neural prosthesis automatically corrects malfunctioning brain circuit activity, with the potential to transform patients' lives. Novela is leading the development of a new era of neurological treatments called Dynamiceuticals, tailored to the dynamics of each person's brain," says Ray Iskander, co-founder and CEO of Novela.
The J. P. Morgan Healthcare Conference is one of the largest healthcare investment symposiums that brings together investors, emerging companies and technological inventors.
"We are excited to showcase our innovative technology to diverse stakeholders at the conference," says Iskander.
About Novela Neurotech
Novela Neurotech, based in Alameda, CA, has been on the forefront of accelerating brain stimulation research. Spun off from Waterloo University in Canada, Novela is developing a full brain stimulation platform Neureka, which includes a smart hardware neural interface and a cloud-based software analysis suite, to aid researchers in developing new treatments. In addition, Novela is working with Dr. Loren Frank, Professor & Howard Hughes Medical Institute Investigator of the UCSF School of Medicine, to standardize brain electrical data, and accelerate the therapeutic discovery process by promoting global scientific collaboration.
Media Contact at Novela:
For more information, please contact Dr. Shelly Fan at email@example.com